Option Care Health stock price target raised to $38 by JMP on strong Q2

Published 31/07/2025, 10:12
Option Care Health stock price target raised to $38 by JMP on strong Q2

Investing.com - JMP Securities raised its price target on Option Care Health (NASDAQ:OPCH) to $38.00 from $36.00 on Thursday, while maintaining a Market Outperform rating following the company’s second-quarter earnings report. The healthcare company, currently valued at $5.02 billion, has demonstrated strong momentum with a 32% year-to-date return and maintains a GREAT financial health score according to InvestingPro analysis.

Option Care Health reported revenue of $1.42 billion for the second quarter, representing 15% year-over-year growth and exceeding both JMP’s estimate of $1.33 billion and the consensus expectation of $1.35 billion.

The healthcare company demonstrated balanced growth across its business segments, with mid-teens percentage increases in both acute and chronic therapies contributing to the revenue outperformance.

Gross profit reached $269.0 million, growing 8% compared to the same period last year and surpassing JMP’s projection of $260.0 million.

Adjusted EBITDA came in at $114.0 million, a 5% year-over-year increase, which topped JMP’s estimate of $108.0 million and the consensus forecast of $110.8 million.

In other recent news, Option Care Health reported its second-quarter earnings for 2025, surpassing Wall Street expectations. The company achieved an earnings per share of $0.41, which was higher than the forecasted $0.38, representing a surprise of 7.89%. Additionally, Option Care Health’s revenue reached $1.42 billion, exceeding the anticipated $1.35 billion. These results highlight the company’s financial performance during the quarter. Despite the positive earnings report, broader market trends and investor concerns were reflected in pre-market trading. This development is part of the recent updates surrounding the company.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.